DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea · Delayed Price · Currency is KRW 5,070.00
-20.00 (-0.39%)
At close: Jan 19, 2026
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 140.08 billion as of January 23, 2026. Its market cap has increased by 5.79% in one year.
Market Cap
140.08B
Enterprise Value
224.58B
Revenue
238.39B
Ranking
n/a
PE Ratio
181.99
Stock Price
5,070.00
Market Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 140.08B, a decrease of -62.12%. That is a compound annual growth rate of -11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 140.08B | -5.30% |
| Dec 30, 2025 | 147.92B | 12.87% |
| Dec 30, 2024 | 131.05B | -16.18% |
| Dec 28, 2023 | 156.35B | -7.82% |
| Dec 29, 2022 | 169.61B | -27.07% |
| Dec 30, 2021 | 232.56B | -3.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 193.99B |
| GREEN CROSS WellBeing | 164.50B |
| Kyung Dong Pharmaceutical | 152.76B |
| PHARMARESEARCH BIO | 147.16B |
| KOREA PHARMA | 137.86B |
| OPTUS Pharmaceutical | 133.76B |
| Pharos iBio | 127.78B |
| HYUNDAI BIOLAND | 126.00B |